Oregon/Hawaii Node, Clinical Trials Network

俄勒冈/夏威夷节点，临床试验网络

• 批准号: 7384329
• 负责人: DENNIS MCCARTY
• 金额: $ 23.5万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-30 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7384329
• 关键词: Adoption; Am 80; Award; Behavioral Medicine; Case Report Form; Cities; Clinical Research; Clinical Trials; Clinical Trials Network; Collaborations; Communication; Communities; Computer Systems Development; Documentation; Drug abuse; Effectiveness; Electronics; Family; Foundations; Goals; Hawaii; Hawaiian population; Health; Health Personnel; Health Sciences; Instruction; Leadership; Medicine; Mission; Modality; Native Americans; Online Systems; Oregon; Participant; Patients; Policy Maker; Population Heterogeneity; Practice based research; Primary Health Care; Progress Reports; Protocols documentation; Publications; Rate; Rehabilitation therapy; Research; Research Infrastructure; Research Personnel; Research Proposals; Research Training; Rural Community; Science; Standards of Weights and Measures; Sum; Testing; Training; Universities; Washington; addiction; base; concept; data management; follow-up; human subject; innovation; member; quality assurance; treatment program

The Oregon/Hawaii Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) is a bi- directional clinical trial partnership that includes community treatment programs (CTPs) and a Regional Research and Training Center (RRTC) hosted at Oregon Health & Science University (with support from the Kaiser Permanente Center for Health Research in Honolulu, Hawaii and Portland, Oregon). Eight multi- modality drug abuse treatment programs located in urban and rural communities in Oregon, Hawaii and Washington State participate in the node: Adapt (Roseburg, OR), CODA (Portland, OR), ChangePoint (Portland, OR and Vancouver, WA), Kaiser Permanente Hawaii Department of Behavioral Medicine (Honolulu, HI), Kaiser Permanente Northwest Department of Addiction Medicine (Salem and Portland,OR and Longview and Vancouver, WA), Native American Rehabilitation Association, Northwest (Portland,OR), New Directions Northwest (Baker City, OR), Willamette Family (Eugene, OR). The application has one specific aim: Continue and expand a clinical research partnership thatparticipates fully in the National Drug Abuse Treatment Clinical Trials Network and provides a) effectiveimplementation and completion of clinical trials including rapid and efficient recruitment of study participants, b) leadership to CTN committees and subcommittees, c) bi-directional research concepts, d) collaborative publicationwith treatment providers and other nodes, and e) a foundation for training and research proposals that enhance CTN capacity. The Node has high standards for participant recruitment and retention in trials, quality assurancereviews, protocol training, participation in CTN leadership, development of systems for electronic case report forms, bi-directional communication, collaboration with other nodes, and good citizenship. TheOregon/Hawaii Node has proven its ability to be a strong and productive CTN member.

国家药物滥用治疗临床试验网络 (CTN) 的俄勒冈州/夏威夷节点是一个双 定向临床试验合作伙伴关系，包括社区治疗计划 (CTP) 和区域治疗计划 研究与培训中心 (RRTC) 主办于俄勒冈健康与科学大学（得到了 位于夏威夷檀香山和俄勒冈州波特兰的凯撒医疗机构健康研究中心）。八多 俄勒冈州、夏威夷州城市和农村社区的药物滥用治疗方案 华盛顿州参与节点：Adapt (Roseburg, OR)、CODA (Portland, OR)、ChangePoint （俄勒冈州波特兰和华盛顿州温哥华），Kaiser Permanente 夏威夷行为医学部 （夏威夷州檀香山），凯撒医疗机构西北成瘾医学部（俄勒冈州塞勒姆和波特兰） 和朗维尤和华盛顿州温哥华），美国原住民康复协会，西北地区（俄勒冈州波特兰）， 新方向西北（俄勒冈州贝克城）、威拉米特家族（俄勒冈州尤金）。 该申请有一个具体目标：继续并扩大参与的临床研究合作伙伴关系 完全纳入国家药物滥用治疗临床试验网络并提供 a) 有效实施 和完成临床试验，包括快速有效地招募研究参与者，b) 领导 CTN 委员会和小组委员会，c) 双向研究概念，d) 合作出版 治疗提供者和其他节点，以及 e) 培训和研究提案的基础，以增强 CTN容量。 该节点对试验中的参与者招募和保留、质量保证审查、 协议培训、参与 CTN 领导、电子病例报告表系统的开发、 双向沟通、与其他节点的协作以及良好的公民意识。俄勒冈/夏威夷 Node 已经证明了其成为强大且高效的 CTN 成员的能力。